We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

111 hedge funds and large institutions have $225M invested in Arena Pharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more call options, than puts

Call options by funds: $1.17M | Put options by funds: $931K

11% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 35

8% less capital invested

Capital invested by funds: $245M → $225M (-$19.6M)

8% less funds holding

Funds holding: 121 → 111 (-10)

56% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 16

Holders
111
Holders Change
-10
Holders Change %
-8.26%
% of All Funds
2.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
39
Reduced
35
Closed
16
Calls
$1.17M
Puts
$931K
Net Calls
+$240K
Net Calls Change
-$861K

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$2.79M
2
Renaissance Technologies
Renaissance Technologies
New York
+$2.08M
3
RCM
RA Capital Management
Massachusetts
+$1.04M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$869K
5
QIM
Quantitative Investment Management
Virginia
+$254K

Top Sellers

1
CCM
Camber Capital Management
Massachusetts
-$19.9M
2
Millennium Management
Millennium Management
New York
-$3.11M
3
State Street
State Street
Massachusetts
-$1.98M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$1.95M
5
AC
Ascend Capital
California
-$1.56M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
101
Geode Capital Management
Massachusetts
$3.29K +$198K +12,365 +8%
Bank of Montreal
102
Bank of Montreal
Ontario, Canada
$3K -$2.96K -185 -57%
PMFA
103
Plante Moran Financial Advisors
Michigan
$3K – – –
MFS
104
MSI Financial Services
Massachusetts
$2K – – –
TRCT
105
Tower Research Capital (TRC)
New York
$1K -$7.21K -450 -95%
IWMPD
106
Integrated Wealth Management (Palm Desert)
California
$1K – – –
JWA
107
JFS Wealth Advisors
Pennsylvania
$1K – – –
FCCM
108
First City Capital Management
Georgia
$197 – – –
N
109
Nuveen
North Carolina
$32 -$1.3K -81 -5%
CCM
110
Camber Capital Management
Massachusetts
– -$19.9M -1,050,000 Closed
Federated Hermes
111
Federated Hermes
Pennsylvania
– -$1.95M -102,370 Closed
AC
112
Ascend Capital
California
– -$1.56M -82,214 Closed
DCM
113
DAFNA Capital Management
California
– -$725K -38,160 Closed
Citadel Advisors
114
Citadel Advisors
Florida
– -$459K -28,668 Closed
Squarepoint
115
Squarepoint
New York
– -$240K -12,620 Closed
BNP Paribas Financial Markets
116
BNP Paribas Financial Markets
France
– -$99.5K -5,234 Closed
ARTA
117
A.R.T. Advisors
New York
– -$98K -5,183 Closed
D.E. Shaw & Co
118
D.E. Shaw & Co
New York
– -$71K -3,749 Closed
Jane Street
119
Jane Street
New York
– -$58K -3,064 Closed
GC
120
Guggenheim Capital
Illinois
– -$30K -1,597 Closed
DTL
121
Dynamic Technology Lab
Singapore
– -$30K -1,579 Closed
HAG
122
HighPoint Advisor Group
Illinois
– -$24K -1,415 Closed
Fisher Asset Management
123
Fisher Asset Management
Washington
– -$21K -1,110 Closed
ST
124
Spot Trading
Illinois
– -$21K -1,105 Closed
1 2 3 4
5

ARNA Hedge Fund Activity: Q1 2016 in Review

111 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2016, worth a combined $225M — down 8% from $245M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ARNA and 7 opened new positions — a net loss of 9 holders — while 35 trimmed existing stakes and 39 added.

The largest buyer was Wellington Management Group, adding an estimated $2.79M. The largest seller was Camber Capital Management, exiting entirely with an estimated $19.9M sold.

  • 111 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2016, down from 121 in Q4 2015.
  • Funds reported $225M of Arena Pharmaceuticals Inc stock for Q1 2016, down 8% quarter-over-quarter.
  • 7 funds opened new Arena Pharmaceuticals Inc positions in Q1 2016 and 16 closed out, a net change of -9 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q1 2016 was Wellington Management Group, an estimated $2.79M added.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2016 was Camber Capital Management, an estimated $19.9M sold.

Based on aggregated 13F filings for Q1 2016.